HK1099297A1 - Quinoline derivatives for use as mycobacterial inhibitors - Google Patents

Quinoline derivatives for use as mycobacterial inhibitors

Info

Publication number
HK1099297A1
HK1099297A1 HK07106483.4A HK07106483A HK1099297A1 HK 1099297 A1 HK1099297 A1 HK 1099297A1 HK 07106483 A HK07106483 A HK 07106483A HK 1099297 A1 HK1099297 A1 HK 1099297A1
Authority
HK
Hong Kong
Prior art keywords
quinoline derivatives
mycobacterial inhibitors
mycobacterial
inhibitors
quinoline
Prior art date
Application number
HK07106483.4A
Other languages
English (en)
Inventor
Jerome Emile Georges Guillemont
Elisabeth Therese Jeanne Pasquier
David Francis Alain Lancois
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1099297A1 publication Critical patent/HK1099297A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
HK07106483.4A 2004-01-29 2007-06-15 Quinoline derivatives for use as mycobacterial inhibitors HK1099297A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04075286 2004-01-29
PCT/EP2005/050375 WO2005075428A1 (en) 2004-01-29 2005-01-28 Quinoline derivatives for use as mycobacterial inhibitors

Publications (1)

Publication Number Publication Date
HK1099297A1 true HK1099297A1 (en) 2007-08-10

Family

ID=34833674

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07106483.4A HK1099297A1 (en) 2004-01-29 2007-06-15 Quinoline derivatives for use as mycobacterial inhibitors

Country Status (21)

Country Link
US (1) US7790894B2 (es)
EP (1) EP1713776B1 (es)
JP (1) JP4919810B2 (es)
KR (1) KR101160183B1 (es)
CN (1) CN1910154B (es)
AP (1) AP2321A (es)
AT (1) ATE395336T1 (es)
AU (1) AU2005210036B2 (es)
BR (1) BRPI0507312A (es)
CA (1) CA2554049C (es)
DE (1) DE602005006744D1 (es)
EA (1) EA011572B9 (es)
ES (1) ES2306098T3 (es)
HK (1) HK1099297A1 (es)
IL (1) IL177101A (es)
MX (1) MXPA06008596A (es)
NO (1) NO337253B1 (es)
NZ (1) NZ547614A (es)
UA (1) UA83875C2 (es)
WO (1) WO2005075428A1 (es)
ZA (1) ZA200606291B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2855B1 (en) * 2005-08-03 2015-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2684B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2685B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
US8741917B2 (en) 2009-01-15 2014-06-03 Rutgers, The State University Of New Jersey Benzo [C] phenanthridines as antimicrobial agents
US20120059026A1 (en) 2009-04-30 2012-03-08 University Of Medicine And Dentistry Of New Jersey Antimicrobial agents
US8933096B2 (en) 2010-06-09 2015-01-13 Rugers, The State University of New Jersey Antimicrobial agents
US9102617B2 (en) 2010-06-25 2015-08-11 Rutgers, The State University Of New Jersey Antimicrobial agents
RU2486175C2 (ru) * 2011-09-12 2013-06-27 Закрытое Акционерное Общество "Фарм-Синтез" Производные хинолина, в частности 5,6,7-замещенные 1-(2-хлорхинолин-3-ил)-4-диметиламино-2-(нафталин-1-ил)-1-фенилбутан-2-олы, способ получения и применение соединений
US9822108B2 (en) 2012-01-13 2017-11-21 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013142712A1 (en) 2012-03-21 2013-09-26 Rutgers, The State University Of New Jersey Antimicrobial agents
EA038350B1 (ru) 2012-04-27 2021-08-12 Янссен Фармацевтика Нв Антибактериальные хинолиновые производные
ES2576491T3 (es) 2012-04-27 2016-07-07 Janssen Pharmaceutica, N.V. Derivados de quinolina antibacterianos
MX358508B (es) 2012-10-16 2018-08-22 Janssen Pharmaceutica Nv Moduladores de quinolinilo unidos a metileno de receptor nuclear de acido retinoico-gamma-t.
ES2628365T3 (es) 2012-10-16 2017-08-02 Janssen Pharmaceutica N.V. Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T
US9303015B2 (en) 2012-10-16 2016-04-05 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORγt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
CA2927182A1 (en) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv Quinolinyl modulators of ror.gamma.t
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
EP3057421B1 (en) 2013-10-15 2019-11-20 Janssen Pharmaceutica NV Alkyl linked quinolinyl modulators of ror(gamma)t
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2017147316A1 (en) 2016-02-25 2017-08-31 Taxis Pharmaceuticals, Inc. Synthetic processes and intermediates
CA3058183A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270123A1 (en) 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
HUP0003364A3 (en) * 1997-06-19 2002-03-28 Sepracor Inc Marlborough Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2717899A (en) * 1998-01-26 1999-08-09 Smithkline Beecham Plc Quinoline derivatives as antibacterials
PL222801B1 (pl) * 2002-07-25 2016-09-30 Janssen Pharmaceutica Nv Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je
AP2188A (en) * 2004-01-23 2010-12-14 Janssen Pharmaceutica Nv Substituted quinolines and their use as mycobacterial inhibitors.

Also Published As

Publication number Publication date
UA83875C2 (ru) 2008-08-26
ZA200606291B (en) 2008-02-27
EP1713776B1 (en) 2008-05-14
JP4919810B2 (ja) 2012-04-18
BRPI0507312A (pt) 2007-06-26
EA011572B9 (ru) 2018-01-31
DE602005006744D1 (de) 2008-06-26
US20070299106A1 (en) 2007-12-27
NO337253B1 (no) 2016-02-22
CN1910154A (zh) 2007-02-07
AP2006003705A0 (en) 2006-08-31
CA2554049A1 (en) 2005-08-18
EP1713776A1 (en) 2006-10-25
MXPA06008596A (es) 2006-08-28
EA011572B1 (ru) 2009-04-28
US7790894B2 (en) 2010-09-07
AU2005210036B2 (en) 2010-12-23
ES2306098T3 (es) 2008-11-01
NZ547614A (en) 2009-04-30
AP2321A (en) 2011-11-16
JP2007519687A (ja) 2007-07-19
IL177101A0 (en) 2006-12-10
CN1910154B (zh) 2011-08-17
AU2005210036A1 (en) 2005-08-18
KR101160183B1 (ko) 2012-06-26
ATE395336T1 (de) 2008-05-15
CA2554049C (en) 2012-12-18
KR20070004597A (ko) 2007-01-09
EA200601391A1 (ru) 2006-12-29
NO20063821L (no) 2006-08-28
WO2005075428A1 (en) 2005-08-18
IL177101A (en) 2012-01-31

Similar Documents

Publication Publication Date Title
HK1099297A1 (en) Quinoline derivatives for use as mycobacterial inhibitors
IL177012A0 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
HK1105592A1 (en) Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors
HK1107348A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
ZA200509319B (en) Quinoline derivatives as phosphodiesterase inhibitors
ZA200710951B (en) Piperidinyl-substituted isoquinolone derivatives as Rhokinase inhibitors
ZA200806148B (en) 2-adamantylurea derivatives as selective 11ß-HSD1 inhibitors
PT2094263E (pt) Derivados da 2-adamantil-butiramida como inibidores seletivos da 11-beta-hsd1
ZA200610771B (en) Quinazolinedolone derivatives as PARP inhibitors
HK1124233A1 (en) Quinoline derivatives as antibacterical agents
HK1104037A1 (en) Piperidine derivatives as renin inhibitors
PT1763517E (pt) Derivados de pirimidina como inibidores 11beta-hsd1
IL198462A0 (en) Diazepane-acetamide derivatives as selective 11??-hsd1 inhibitors
HK1100927A1 (en) Substituted quinolines and their use as mycobacterial inhibitors
GB0421355D0 (en) Inhibitors